AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25456793 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-technology assisted reproduction
Number of subjects: 378
Study 23545667 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir/lamivudine (ABC/3TC)
Number of subjects: 109
Study 23545667 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir/emtricitabine (TDF/FTC)
Number of subjects: 109
Study 21464406 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX4 plus PTK/ZK
Number of subjects: 1168
Study 21464406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1168
Study 21464406 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX4 plus PTK/ZK (in patients with high serum LDH)
Number of subjects: 1168
Study 21464406 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in patients with high serum LDH)
Number of subjects: 1168
Study 18511076 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 21
Study 18511076 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 21
Study 18511076 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 21
Study 18511076 — intervention group
Group type: COMPARATOR
Intervention: Control (Healthy Controls)
Number of subjects: 21
Study 18511076 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (All Antidepressants)
Number of subjects: 21
Study 16670691 — intervention group
Group type: EXPERIMENTAL
Intervention: B6 -50 (50 mg vitamin B6 daily for 14 days)
Number of subjects: 51
Study 16670691 — intervention group
Group type: EXPERIMENTAL
Intervention: B6 -100 (100 mg vitamin B6 daily for 14 days)
Number of subjects: 51
Study 16670691 — intervention group
Group type: COMPARATOR
Intervention: Control (no vitamin B6 supplementation, n = 20)
Number of subjects: 51
Study 15178989 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent-Supported Percutaneous Angioplasty
Number of subjects: 670
Study 15178989 — intervention group
Group type: COMPARATOR
Intervention: Endarterectomy
Number of subjects: 670
Study 11383780 — intervention group
Group type: EXPERIMENTAL
Intervention: Celsior
Number of subjects: 131
Study 11383780 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 131
Study 9737359 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithyroid drug plus thyroxine for 18 months
Number of subjects: 174
Study 9737359 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy
Number of subjects: 174
Study 9737359 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-131
Number of subjects: 174
Study 9737359 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 174
Study 9737359 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 174
Study 8043708 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 27
Study 2498658 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (10 mg per kilogram of body weight per day), administered orally for two months
Number of subjects: 60
Study 2498658 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered for two months
Number of subjects: 60
Study 4974510 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphamethoxazole plus one-fifth its weight of trimethoprim (Septrin)
Number of subjects: 111
Study 4974510 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphamethoxazole plus one-tenth its weight of trimethoprim
Number of subjects: 111
Study 4974510 — intervention group
Group type: COMPARATOR
Intervention: Sulphamethoxazole alone
Number of subjects: 111